Spectral Diagnostics (OTCMKTS:EDTXF) Stock Price Down 1% – Here’s Why

Spectral Diagnostics Inc. (OTCMKTS:EDTXF)’s share price was down 1% during mid-day trading on Friday . The company traded as low as $0.9278 and last traded at $0.9401. Approximately 12,700 shares traded hands during mid-day trading, an increase of 12% from the average daily volume of 11,338 shares. The stock had previously closed at $0.95.

Spectral Diagnostics Trading Down 1.0%

The firm has a market cap of $275.04 million, a price-to-earnings ratio of -8.55 and a beta of 0.07. The firm’s 50 day simple moving average is $0.96 and its two-hundred day simple moving average is $0.95.

Spectral Diagnostics (OTCMKTS:EDTXF) last released its earnings results on Friday, November 7th. The company reported ($0.08) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.01) by ($0.07). The firm had revenue of $0.49 million during the quarter, compared to analysts’ expectations of $0.54 million.

About Spectral Diagnostics

Spectral Medical Inc focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, and internationally. The company markets Endotoxin Activity Assay, a rapid in vitro diagnostic test for the detection of components of gram negative bacterial cell wall; and Polymyxin B Hemoperfusion, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream. It also develops and manufactures monoclonal and polyclonal antibodies, recombinant cardiac proteins, and calibrators for use in the research and development, as well as products that are manufactured by other diagnostic companies.